Bradley Case - Mitesco Pres Clinic

MITI Stock  USD 0.46  0.14  23.33%   

Insider

Bradley Case is Pres Clinic of Mitesco
Phone844 383 8689
Webhttps://www.mitescoinc.com

Mitesco Management Efficiency

The company has return on total asset (ROA) of (0.7715) % which means that it has lost $0.7715 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (16.5201) %, meaning that it created substantial loss on money invested by shareholders. Mitesco's management efficiency ratios could be used to measure how well Mitesco manages its routine affairs as well as how well it operates its assets and liabilities.
Mitesco currently holds 8.17 M in liabilities with Debt to Equity (D/E) ratio of 4.62, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Mitesco has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Mitesco until it has trouble settling it off, either with new capital or with free cash flow. So, Mitesco's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mitesco sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mitesco to invest in growth at high rates of return. When we think about Mitesco's use of debt, we should always consider it together with cash and equity.
Mitesco, Inc. operates medical clinics under the The Good Clinic name in North East Minneapolis, the United States. The company was formerly known as True Nature Holding, Inc. and changed its name to Mitesco, Inc. in April 2020. Mitesco operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 27 people. Mitesco [MITI] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Mitesco Leadership Team

Elected by the shareholders, the Mitesco's board of directors comprises two types of representatives: Mitesco inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mitesco. The board's role is to monitor Mitesco's management team and ensure that shareholders' interests are well served. Mitesco's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mitesco's outside directors are responsible for providing unbiased perspectives on the board's policies.
Thomas Brodmerkel, Chairman CFO
Ronald Riewold, Strategic Advisor
Jenny Lindstrom, Chief Sec
Bradley Case, Pres Clinic
Michael Howe, Chief Clinic
Lawrence Diamond, CEO Director
Louis Deluca, B Consultant

Mitesco Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Mitesco a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Mitesco Pink Sheet

Mitesco financial ratios help investors to determine whether Mitesco Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mitesco with respect to the benefits of owning Mitesco security.